Safety Alerts Saves Lives
Safety Alerts  
 
Home Privacy About Us Contact Us Change Preferences
spacer.gif (43 bytes)
SafetyAlerts
December 5,  2001

Hormone Replacement Therapy May Be Option for Some Breast Cancer Survivors

http://www.breastlink.org/ - The Web Site That Presents the Science Behind Breast Cancer News in English and Spanish

 (SafetyAlerts) - The Breast Cancer Care & Research Fund's web site, Breastlink.org, features a study of some 2,755 breast cancer patients showing that women who used hormone replacement therapy (HRT) after diagnosis had significantly fewer recurrences and deaths than nonusers. Similarly, a review of the literature on use of hormone replacement therapy by breast cancer survivors revealed no adverse effect on recurrence. However, experts urge caution. "If a breast cancer survivor is interested in taking HRT, it should be very clear why she's interested and what alternatives there are for the problem," says Rena Sellin, M.D., Professor of Medicine, M.D. Anderson Cancer Center, Houston, TX.

This month's Breastlink.org also features articles on the following topics:

Risk of Breast Cancer Varies by Age and Ethnicity

The widely publicized "one-in-nine" lifetime risk of developing breast cancer is misleading and causes many women to overestimate their actual risk. This population study of California women shows that risk of breast cancer varies according to a woman's current age and ethnicity. Expert commentary is provided by Joseph Costantino, PhD, Associate Professor of Biostatistics, Graduate School of Public Health University of Pittsburgh.

Additional Chemotherapy Relieves Symptoms of Locally Recurrent Advanced Breast Cancer

British researchers report that more than one course of systemic chemotherapy may be an important palliative treatment for breast cancer patients with recurrent chest wall disease. Expert commentary is provided by Kelly K. Hunt, MD, Chief of Breast Surgery, Nellie B. Connally Breast Center, University of Texas, M.D. Anderson Cancer Center.

Weight Gained by Premenopausal Chemotherapy Patients Resembles Weight Gained During Menopause.

Researchers at Duke, Harvard, and the National Cancer Institute found that premenopausal breast cancer patients treated with chemotherapy gained abdominal fat, not from overeating, but from reduced energy expenditure. This mimicked the kind of weight increase seen in menopausal women. Roanne Segal, MD, Medical Director, Oncology Rehabilitation Program, Ottawa Regional Cancer Centre, provides the expert commentary.

John Link, MD, founder of The Breast Cancer Care & Research Fund, says: "Never has there been a more exciting or more hopeful time for breast cancer research and treatment. We are beginning to understand this disease at the molecular and genetic levels. Through regular screening we are diagnosing breast cancer at earlier stages, and death rates from breast cancer are steadily declining. Women need to be informed to take advantage of the extraordinary changes in treatment that are available at cancer centers and in clinical trials today. In the near future, these changes will provide even more options for breast cancer patients."

Source: PRNewswire.

 
Selected Recent Recalls


Health Professional:

Did you know?
During 2000 there were over
1050 products recalled in the United
States for safety reasons!

How many did you hear about?

Sign-up for SafetyAlerts by Email -
The free internet newsletter that could
some day literally save your life - or
the life of someone you know.

 

The information contained herein has been obtained from sources that the Company believes to be reliable, however, the Company has not independently verified or confirmed the information and the recipient acknowledges that no representations or warranties are being made in connection with the use of the information.